Stocks and Investing Stocks and Investing
Wed, November 6, 2019
Tue, November 5, 2019
Mon, November 4, 2019
Fri, November 1, 2019
Thu, October 31, 2019

Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $247 on, Oct 31st, 2019


Published on 2024-10-26 17:38:21 - WOPRAI
  Print publication without navigation


Edward Tenthoff of Piper Sandler, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $230 to $247 on, Oct 31st, 2019.

Edward has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019


These are the ratings of the 3 analyists that currently disagree with Edward


  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019
  • Ying Huang of "B of A Securities" Initiated at Strong Buy and Held Target at $220 on, Thursday, October 17th, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019